Drug name - Sitavig
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8791127 | EPI HLTH | Mucosal bioadhesive slow release carrier for delivering active principles |
Mar, 2027
(4 years from now) | |
| US8747896 | EPI HLTH | Mucosal bioadhesive slow release carrier for delivering active principles |
Jun, 2027
(4 years from now) | |
| US8592434 | EPI HLTH | Mucoadhesive buccal tablets for the treatment of orofacial herpes |
Jun, 2030
(7 years from now) | |
Drugs and Companies using ACYCLOVIR ingredient
Treatment: Treatment of herpes labialis
Dosage: TABLET;BUCCAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 50MG | TABLET;BUCCAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.